This downturn is different.
“We should see a reasonably rapid recovery.”
Investing in a promising early-stage healthcare company.
Commercialization is key.
Alléger les coûts de la bioproduction
Reducing the costs of biologic manufacturing. (In french)
Irish America Business 100
Mark Goldstone is named in 2022s Irish America Business 100.
Healthcare remains robust.
Bloomberg Businessweek. Carol Massar and Tim Stenovec interview Youssef Sebban. May 31, 2022
Investing In Early-Stage Healthcare Companies
Looks at what’s been driving the record investment into healthcare, what to look for and why commercialization is key.
The Future of Wearable Healthtech.
Reviews the innovation drivers and the dramatic growth potential of this very significant market.
This downturn is different.
Youssef Sebban interview by Carol Massar and Tim Stenovec on Bloomberg Businessweek.
AGELESS THERAPEUTICS
Improving protein therapeutics through anti-glycation modification.